This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Gain insight into research trends and influential papers with Research Intelligence.
doi.org/10.1093/annonc/mdz394.059
Other

Efficacy and safety of nivolumab (Nivo) + ipilimumab (Ipi) in patients (pts) with recurrent/metastatic (R/M) cervical cancer: Results from CheckMate 358

..., Kathleen N. Moore
75
Annals of Oncology56.70
Volume: 30, Pages: v898 - v899
Published: Oct 1, 2019
Abstract
No abstract.
Paper Fields
Paper Details
Title
Efficacy and safety of nivolumab (Nivo) + ipilimumab (Ipi) in patients (pts) with recurrent/metastatic (R/M) cervical cancer: Results from CheckMate 358
DOI
doi.org/10.1093/annonc/mdz394.059
Published Date
Oct 1, 2019
Journal
Annals of Oncology
Volume
30
Pages
v898 - v899
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.